Literature DB >> 7107388

Potentiation in vivo of melphalan activity by nitroimidazole compounds.

P W Sheldon, E L Batten.   

Abstract

Many nitroimidazole compounds have been shown to potentiate the activity of melphalan against the murine anaplastic MT tumor. The degree of potentiation achieved by these compounds probably depends on their octanol-water partition coefficient and electron affinity: for the greater the partition coefficient of electron affinity, the greater the potentiation. The mechanism of this potentiation remains uncertain. However, it is not due to either nitroimidazole-induced hypothermia, or to the elimination of the recovery from melphalan-induced potentially lethal damage (PLD).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107388     DOI: 10.1016/0360-3016(82)90701-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Potentiation of CCNU activity by misonidazole in metastases.

Authors:  D W Siemann; K L Alliet
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

2.  Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.

Authors:  M R Horsman; D M Brown; D G Hirst; J M Brown
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

3.  Preclinical pharmacokinetics of benznidazole.

Authors:  P Workman; R A White; M I Walton; L N Owen; P R Twentyman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

4.  Effect of the nitroimidazole Ro 03-8799 on the activity of chemotherapeutic agents against a murine tumour in vivo.

Authors:  P W Sheldon; P Gibson
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

5.  Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.

Authors:  C Grau; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

6.  Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.

Authors:  M R Horsman; J W Evans; J M Brown
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

7.  Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.

Authors:  P W Sheldon; E L Batten; G E Adams
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

8.  Chemosensitization by lipophilic nitroimidazoles.

Authors:  P R Twentyman; P Workman
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640

9.  Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.

Authors:  P Workman; P R Twentyman
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.